Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:


Articles on the impact, diagnosis and treatment of the novel coronavirus and COVID-19

Clover Bio’s COVID Vaccine Effective as Booster Against Omicron Variants

Clover Starts Phase III Trial of COVID Vaccine as a Booster to Other Vaccines

Junshi’s Novel SARS-CoV-2 Therapy Out-Performs Pfizer’s Paxlovid

CanSino One-Shot COVID Vaccine Accepted by WHO

Ascentage Oncology Drug Effective in Preclinical Tests for COVID Cytokine Storm

ChinaBio Event
Beijing and Digital
November 8-11, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022